Position in GH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,200
+$383 QoQ
Shares Held
8
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#570
of 594 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Concord Wealth Partners holds $638,372 across 6 Diagnostics & Research names. GH ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
649 | $325,382 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
311 | $163,722 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
92 | $117,530 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
94 | $18,162 | |
| 5 | WAT |
Waters Corp /De/
|
33 | $12,376 | |
| 6 | GH |
Guardant Health, Inc.
This page
|
8 | $1,200 |
All Filings in GH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,200 | 8 | Shares | Sole | 2026-07-27 | |
| 2025-12-31 | $817 | 8 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $499 | 8 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $416 | 8 | Shares | Sole | 2025-07-25 | |
| No filing history on record for this holder in this stock. | ||||||